High dose therapy and autologous stem cell transplant in older adults with multiple myeloma

Randomized trials showing that high dose therapy with autologous stem cell transplant (ASCT) improved overall survival in multiple myeloma (MM) excluded patients over age 65. To compare outcomes of older adults with MM who underwent ASCT with non-transplant strategies, we identified 146 patients age...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Bone Marrow Transplant
Autors principals: Wildes, Tanya M, Finney, Joseph D, Fiala, Mark, Gao, Feng, Vij, Ravi, Stockerl-Goldstein, Keith, Carson, Kenneth R, Mikhael, Joseph, Colditz, Graham
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526374/
https://ncbi.nlm.nih.gov/pubmed/25961765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.106
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars